News | January 04, 2023
Harbor Healthcare advises a California long-term care pharmacy on its sale & strategic partnership
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
The strategic acquirer maintains a nationwide presence in the LTC pharmacy space
Kyfora Bio will focus on the synthesis of cationic polymers, lipids, and other materials used in nucleic acid delivery for cell and gene therapies.
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
Greenko ZeroC will supply Carbon Free Energy and enable Green Hydrogen along with its various chemical derivatives.
Lumpi-ProVacind is used for the prophylactic immunization of animals against Lumpy Skin Disease, which illicit protection for about one year
The company has plans to launch this Vaccine by the end of 2023 after completing the required field studies and obtaining regulatory approvals
The cash and debt free consideration value is €370 million.
J. B. Chemicals & Pharmaceuticals has informed that the acquisition of the Razel franchise from Glenmark Pharmaceuticals Limited has been successfully completed.
Selexipag tablet is indicated in adults for the treatment of pulmonary arterial hypertension to delay disease progression and reduce the risk of hospitalization for PAH
Indira IVF integrates diagnostics services with a special focus on women & child care to increase accessibility for patients
Subscribe To Our Newsletter & Stay Updated
